# Phase 1 PK Study of XOMA 3AB

> **NCT01357213** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 24 (actual)

## Conditions studied

- Botulism

## Interventions

- **DRUG:** XOMA 3AB
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01357213
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2012-05
- **Final completion:** 2013-05
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2014-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01357213

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01357213, "Phase 1 PK Study of XOMA 3AB". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01357213. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*